Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT01106339 Completed - Depression Clinical Trials

Immune Patterns in Pain Patients DSM-IV

IPPPDIV
Start date: August 2007
Phase: N/A
Study type: Observational

The purpose of this study is to define subgroups of patients with somatoform disorders due to DSM-IV by immunological, psychological and genetic characterization.

NCT ID: NCT01105507 Completed - Clinical trials for Cryopyrin Associated Periodic Syndrome

The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada

Start date: August 2010
Phase: Phase 3
Study type: Interventional

This study will assess the safety, tolerability and efficacy of canakinumab treatment in Canadian patient diagnosed with cryopyrin-associated periodic syndrome over a period of 18 months.

NCT ID: NCT01105325 Terminated - Clinical trials for Acute Coronary Syndrome

Evaluation of Compliance With Management of Acute Coronary Syndrome on Discharge From Cardiac Intensive Care

SCAVANCE
Start date: April 2010
Phase: N/A
Study type: Observational

To study compliance with secondary prevention during the first months following discharge from the cardiac intensive care unit (CIC) of patients experiencing a first episode of acute coronary syndrome : quantitative compliance over 3 months with the two principal treatments of the prescription (a statin - rosuvastatin, Crestor® and a platelet aggregation inhibitor - clopidogrel, Plavix®), using an electronic measure system ("intelligent blister" pack®);

NCT ID: NCT01104610 Withdrawn - Clinical trials for Obesity Hypoventilation Syndrome

Target Volume Mode Controlled Ventilator in Obesity Hypoventilation Syndrome

OVO
Start date: May 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the evolution of daytime partial pressure of carbon dioxide in the blood (PaCO2) after 6 weeks of noninvasive ventilation-pressure support ventilation (NIV-PSV) with target volume versus continuous positive airway pressure (CPAP) alone versus NIV-PSV.

NCT ID: NCT01104415 Completed - Carcinoid Syndrome Clinical Trials

Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome

Start date: June 15, 2010
Phase: Phase 2
Study type: Interventional

The purpose of the study is to evaluate the safety and tolerability of orally administered telotristat etiprate (LX1606) in participants with symptomatic carcinoid syndrome.

NCT ID: NCT01102868 Completed - Clinical trials for Carpal Tunnel Syndrome

IMS-treatment and Canalis Carpi Syndrome

Start date: April 2009
Phase: N/A
Study type: Interventional

Carpal tunnel syndrome is a condition in which the median nerve is compressed at the wrist, leading to paresthesias, numbness and muscle weakness in the hand. Treatment of the condition often involves surgery. In this study we wish to se if there is an effect of using intramuscular stimulation (IMS) to release the tension of nervus medianus in the lower arm. The study will be performed by randomization to IMS of musculus pronator teres or a control ("Scam IMS treatment" to the acupuncture point Li11). The two insertion points are approximately 1cm apart in the lower arm.

NCT ID: NCT01101880 Completed - Clinical trials for Chronic Myelomonocytic Leukemia

Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm

Start date: August 2010
Phase: Phase 2
Study type: Interventional

This phase II trial is studying how well giving clofarabine and cytarabine together with filgrastim works in treating patients with newly diagnosed acute myeloid leukemia (AML), advanced myelodysplastic syndrome (MDS), and/or advanced myeloproliferative neoplasm. Drugs used in chemotherapy, such as clofarabine and cytarabine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving the drugs in different doses may kill more cancer cells. Colony stimulating factors, such as filgrastim, may increase the number of immune cells found in bone marrow or peripheral blood and may help the immune system recover from the side effects of chemotherapy.

NCT ID: NCT01100684 Completed - Clinical trials for Diarrhea Predominant Irritable Bowel Syndrome

Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)

Start date: May 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether asimadoline is safe and effective at treating D-IBS.

NCT ID: NCT01099306 Completed - Metabolic Syndrome Clinical Trials

Pharmacist - Physician Collaborative Approach to the Management of Metabolic Syndrome

Start date: March 2009
Phase: N/A
Study type: Interventional

This study devised an experimental focused pharmaceutical care program, allowed a clinical pharmacist to work in a physician office to assess and manage patients' metabolic syndrome status and its individual components. This study described the clinical benefits of physician- clinical pharmacist interaction in achieving improved glycemic control, lipid and blood pressure measurements, involving medication, diet, physical activity and patient heath care counseling.

NCT ID: NCT01098292 Completed - Fibromyalgia Clinical Trials

Observational Study of Control Participants for the MAPP Research Network

MAPP-Control
Start date: December 2009
Phase: N/A
Study type: Observational

The Control Study for the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network has been established to focus on a broader approach to the study of Interstitial Cystitis (IC)/Painful Bladder Syndrome (PBS) in men and women, and Chronic Prostatitis (CP)/Chronic Pelvic Pain Syndrome (CPPS) in men, than previously undertaken. Participants with no Urologic Pelvic Pain Syndromes as well as participants with specific conditions (Fibromyalgia (FM), Irritable Bowel Syndrome (IBS), Chronic Fatigue Syndrome (CFS)) are being recruited for the Trans-MAPP Control Study. These participants will act as a reference/control group for the Trans-MAPP Epidemiology & Phenotyping (EP) Study. As with many chronic pain disorders, IC and CP are poorly understood, and treatment is often not helpful. The goal of this study is to better understand how pain is felt in people with IC or CP. The MAPP Control Study is an observational study that will enroll participants from 6 Discovery Sites and 3 Satellite Sites across the U.S. The investigators will ask questions and gather information about the health and life of the participants for research purposes. The investigators hope that this study will lead to improvement in the treatment of IC and CP.